Clinical trials
Recruiting Neoplasms by Site trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 11 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Massachusetts General Hospital | 2 |
| Pfizer | 2 |
| Alterome Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Cerenome | 1 |
| Cogent Biosciences, Inc. | 1 |
| Corcept Therapeutics | 1 |
| Ensem Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 30 |
| Neoplasms | 28 |
| Lung Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Neoplasm Metastasis | 8 |
| Neoplasms by Histologic Type | 8 |
| Carcinoma | 7 |
| Lung Diseases | 7 |
| Respiratory Tract Diseases | 7 |
| Respiratory Tract Neoplasms | 7 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.